查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1508473

分子腫瘤學市場 - 全球產業分析、規模、佔有率、成長、趨勢和預測，2024-2034 年

Molecular Oncology Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2024-2034
出版日期: | 出版商: Transparency Market Research | 英文 145 Pages | 商品交期: 2-10個工作天內

價格

分子腫瘤學市場 - 報告範圍

TMR 關於全球分子腫瘤學市場的報告研究了過去以及當前的成長趨勢和機會，以獲得 2024 年至 2034 年預測期內市場指標的寶貴見解。年期間，考慮2024年為基準年，2034年為預測年。報告也提供了2024年至2034年全球分子腫瘤學市場的年複合成長率（CAGR%）。

該報告是經過廣泛研究後編寫的。初級研究涉及大部分研究工作，其中分析師對關鍵意見領袖、行業領導者和輿論製造者進行了採訪。二次研究涉及參考主要參與者的產品文獻、年度報告、新聞稿和相關文件，以了解分子腫瘤學市場。

市場概況
2023年市場價值 23億美元
2034 年市場價值 74 億美元
複合年成長率 11%

該報告深入探討了全球分子腫瘤學市場的競爭格局。全球分子腫瘤學市場的主要參與者已被確定，並且每一位參與者都已根據各種屬性進行了分析。公司概況、財務狀況、最新發展和 SWOT 是本報告中介紹的全球分子腫瘤學市場參與者的屬性。

目錄

第1章：前言

第 2 章：假設與研究方法

第 3 章：執行摘要：全球市場

第 4 章：市場概述

  • 介紹
  • 概述
  • 市場動態
  • 2020-2034 年全球市場分析與預測

第 5 章：關鍵見解

  • 主要併購
  • 按地區/全球分類的監管情景
  • 癌症盛行率
  • COVID-19 影響分析

第 6 章：全球市場分析與預測：依產品分類

  • 簡介與定義
  • 主要發現/進展
  • 2020-2034 年各產品市場價值預測
    • 儀器
    • 試劑
    • 其他
  • 按產品分類的市場吸引力

第 7 章：全球市場分析與預測：按應用分類

  • 簡介與定義
  • 主要發現/進展
  • 2020-2034 年按應用分類的市場價值預測
    • 肺癌
    • 乳癌
    • 大腸直腸癌
    • 卵巢癌
    • 胰腺癌
    • 其他
  • 按應用分類的市場吸引力

第 8 章：全球市場分析與預測：依技術分類

  • 簡介與定義
  • 主要發現/進展
  • 2020-2034 年技術市場價值預測
    • PCR（rt-PCR、d-PCR）
    • NGS（次世代定序）
    • 微陣列
    • FISH（螢光原位雜合技術）
    • 其他
  • 技術的市場吸引力

第 9 章：全球市場分析與預測：按最終用戶

  • 簡介與定義
  • 主要發現/進展
  • 2020-2034 年最終用戶市場價值預測
    • 醫院和診所
    • 診斷實驗室
    • 癌症中心和專科診所
    • 其他（政府和公共衛生機構）
  • 最終用戶的市場吸引力

第 10 章：全球市場分析與預測：按地區

  • 主要發現
  • 各地區市場價值預測
    • 北美洲
    • 歐洲
    • 亞太地區
    • 拉丁美洲
    • 中東和非洲
  • 按國家/地區分類的市場吸引力

第 11 章：北美市場分析與預測

  • 美國
  • 加拿大

第 12 章：歐洲市場分析與預測

  • 德國
  • 英國
  • 法國
  • 西班牙
  • 義大利
  • 歐洲其他地區

第 13 章：亞太市場分析與預測

  • 中國
  • 日本
  • 印度
  • 澳洲和紐西蘭
  • 亞太地區其他地區

第 14 章：拉丁美洲市場分析與預測

  • 巴西
  • 墨西哥
  • 拉丁美洲其他地區

第 15 章：中東和非洲市場分析與預測

  • 海灣合作理事會國家
  • 南非
  • 中東和非洲其他地區

第16章：競爭格局

  • 市場參與者 - 競爭矩陣（依公司層級和規模）
  • 公司簡介
    • Thermo Fisher Scientific Inc.
    • Illumina, Inc.
    • Qiagen NV
    • Agilent Technologies, Inc.
    • Abbott Laboratories
    • Bio-Rad Laboratories, Inc.
    • Roche Diagnostics
    • Genomic Health, Inc.
    • Myriad Genetics, Inc.
Product Code: TMRGL86057

Molecular Oncology Market - Scope of Report

TMR's report on the global molecular oncology market studies the past as well as the current growth trends and opportunities to gain valuable insights of the indicators of the market during the forecast period from 2024 to 2034. The report provides revenue of the global molecular oncology market for the period 2018-2034, considering 2024 as the base year and 2034 as the forecast year. The report also provides the compound annual growth rate (CAGR %) of the global molecular oncology market from 2024 to 2034.

The report has been prepared after an extensive research. Primary research involved bulk of the research efforts, wherein analysts carried out interviews with key opinion leaders, industry leaders, and opinion makers. Secondary research involved referring to key players' product literature, annual reports, press releases, and relevant documents to understand the molecular oncology market.

Market Snapshot
Market Value in 2023US$ 2.3 Bn
Market Value in 2034US$ 7.4 Bn
CAGR11%

Secondary research also included Internet sources, statistical data from government agencies, websites, and trade associations. Analysts employed a combination of top-down and bottom-up approaches to study various attributes of the global molecular oncology market.

The report includes an elaborate executive summary, along with a snapshot of the growth behavior of various segments included in the scope of the study. Moreover, the report throws light on the changing competitive dynamics in the global molecular oncology market. These serve as valuable tools for existing market players as well as for entities interested in participating in the global molecular oncology market.

The report delves into the competitive landscape of the global molecular oncology market. Key players operating in the global molecular oncology market have been identified and each one of these has been profiled in terms of various attributes. Company overview, financial standings, recent developments, and SWOT are the attributes of players in the global molecular oncology market profiled in this report.

Key Questions Answered in Global molecular oncology Market Report:

  • What is the sales/revenue generated by molecular oncology across all regions during the forecast period?
  • What are the opportunities in the global molecular oncology market?
  • What are the major drivers, restraints, opportunities, and threats in the market?
  • Which regional market is set to expand at the fastest CAGR during the forecast period?
  • Which segment is expected to generate the highest revenue globally in 2034?
  • Which segment is projected to expand at the highest CAGR during the forecast period?
  • What are the market positions of different companies operating in the global market?

Molecular Oncology Market - Research Objectives and Research Approach

The comprehensive report on the global molecular oncology market begins with an overview, followed by the scope and objectives of the study. The report provides detailed explanation of the objectives behind this study and key vendors and distributors operating in the market and regulatory scenario for approval of products.

For reading comprehensibility, the report has been compiled in a chapter-wise layout, with each section divided into smaller ones. The report comprises an exhaustive collection of graphs and tables that are appropriately interspersed. Pictorial representation of actual and projected values of key segments is visually appealing to readers. This also allows comparison of the market shares of key segments in the past and at the end of the forecast period.

The report analyzes the global molecular oncology market in terms of product, end-user, and region. Key segments under each criterion have been studied at length, and the market share for each of these at the end of 2034 has been provided. Such valuable insights enable market stakeholders in making informed business decisions for investment in the global molecular oncology market.

Table of Contents

1. Preface

  • 1.1. Market Definition and Scope
  • 1.2. Market Segmentation
  • 1.3. Key Research Objectives
  • 1.4. Research Highlights

2. Assumptions and Research Methodology

3. Executive Summary: Global Molecular Oncology Market

4. Market Overview

  • 4.1. Introduction
    • 4.1.1. Product Definition
    • 4.1.2. Industry Evolution / Developments
  • 4.2. Overview
  • 4.3. Market Dynamics
    • 4.3.1. Drivers
    • 4.3.2. Restraints
    • 4.3.3. Opportunities
  • 4.4. Global Molecular Oncology Market Analysis and Forecasts, 2020-2034

5. Key Insights

  • 5.1. Key Mergers & Acquisitions
  • 5.2. Regulatory Scenario by Region/Globally
  • 5.3. Prevalence of Cancer
  • 5.4. COVID-19 Impact Analysis

6. Global Molecular Oncology Market Analysis and Forecasts, By Product

  • 6.1. Introduction & Definition
  • 6.2. Key Findings / Developments
  • 6.3. Market Value Forecast By Product, 2020-2034
    • 6.3.1. Instruments
    • 6.3.2. Reagents
    • 6.3.3. Others
  • 6.4. Market Attractiveness By Product

7. Global Molecular Oncology Market Analysis and Forecasts, By Application

  • 7.1. Introduction & Definition
  • 7.2. Key Findings / Developments
  • 7.3. Market Value Forecast By Application, 2020-2034
    • 7.3.1. Lung Cancer
    • 7.3.2. Breast Cancer
    • 7.3.3. Colorectal Cancer
    • 7.3.4. Ovarian Cancer
    • 7.3.5. Pancreatic Cancer
    • 7.3.6. Others
  • 7.4. Market Attractiveness By Application

8. Global Molecular Oncology Market Analysis and Forecasts, By Technology

  • 8.1. Introduction & Definition
  • 8.2. Key Findings / Developments
  • 8.3. Market Value Forecast By Technology, 2020-2034
    • 8.3.1. PCR (rt-PCR, d-PCR)
    • 8.3.2. NGS (Next Generation Sequencing)
    • 8.3.3. Microarray
    • 8.3.4. FISH (Fluorescent in situ-hybridization)
    • 8.3.5. Others
  • 8.4. Market Attractiveness By Technology

9. Global Molecular Oncology Market Analysis and Forecasts, By End-user

  • 9.1. Introduction & Definition
  • 9.2. Key Findings / Developments
  • 9.3. Market Value Forecast By End-user, 2020-2034
    • 9.3.1. Hospitals and Clinics
    • 9.3.2. Diagnostic Laboratories
    • 9.3.3. Cancer Centers and Specialty Clinics
    • 9.3.4. Others (Government and Public Health Agencies)
  • 9.4. Market Attractiveness By End-user

10. Global Molecular Oncology Market Analysis and Forecasts, By Region

  • 10.1. Key Findings
  • 10.2. Market Value Forecast By Region
    • 10.2.1. North America
    • 10.2.2. Europe
    • 10.2.3. Asia Pacific
    • 10.2.4. Latin America
    • 10.2.5. Middle East & Africa
  • 10.3. Market Attractiveness By Country/Region

11. North America Molecular Oncology Market Analysis and Forecast

  • 11.1. Introduction
    • 11.1.1. Key Findings
  • 11.2. Market Value Forecast By Product, 2020-2034
    • 11.2.1. Instruments
    • 11.2.2. Reagents
    • 11.2.3. Others
  • 11.3. Market Value Forecast By Application, 2020-2034
    • 11.3.1. Lung Cancer
    • 11.3.2. Breast Cancer
    • 11.3.3. Colorectal Cancer
    • 11.3.4. Ovarian Cancer
    • 11.3.5. Pancreatic Cancer
    • 11.3.6. Others
  • 11.4. Market Value Forecast By Technology, 2020-2034
    • 11.4.1. PCR (rt-PCR, d-PCR)
    • 11.4.2. NGS (Next Generation Sequencing)
    • 11.4.3. Microarray
    • 11.4.4. FISH (Fluorescent in situ-hybridization)
    • 11.4.5. Others
  • 11.5. Market Value Forecast By End-user, 2020-2034
    • 11.5.1. Hospitals and Clinics
    • 11.5.2. Diagnostic Laboratories
    • 11.5.3. Cancer Centers and Specialty Clinics
    • 11.5.4. Others (Government and Public Health Agencies)
  • 11.6. Market Value Forecast By Country, 2020-2034
    • 11.6.1. U.S.
    • 11.6.2. Canada
  • 11.7. Market Attractiveness Analysis
    • 11.7.1. By Product
    • 11.7.2. By Application
    • 11.7.3. By Technology
    • 11.7.4. By End-user
    • 11.7.5. By Country

12. Europe Molecular Oncology Market Analysis and Forecast

  • 12.1. Introduction
    • 12.1.1. Key Findings
  • 12.2. Market Value Forecast By Product, 2020-2034
    • 12.2.1. Instruments
    • 12.2.2. Reagents
    • 12.2.3. Others
  • 12.3. Market Value Forecast By Application, 2020-2034
    • 12.3.1. Lung Cancer
    • 12.3.2. Breast Cancer
    • 12.3.3. Colorectal Cancer
    • 12.3.4. Ovarian Cancer
    • 12.3.5. Pancreatic Cancer
    • 12.3.6. Others
  • 12.4. Market Value Forecast By Technology, 2020-2034
    • 12.4.1. PCR (rt-PCR, d-PCR)
    • 12.4.2. NGS (Next Generation Sequencing)
    • 12.4.3. Microarray
    • 12.4.4. FISH (Fluorescent in situ-hybridization)
    • 12.4.5. Others
  • 12.5. Market Value Forecast By End-user, 2020-2034
    • 12.5.1. Hospitals and Clinics
    • 12.5.2. Diagnostic Laboratories
    • 12.5.3. Cancer Centers and Specialty Clinics
    • 12.5.4. Others (Government and Public Health Agencies)
  • 12.6. Market Value Forecast By Country, 2020-2034
    • 12.6.1. Germany
    • 12.6.2. U.K.
    • 12.6.3. France
    • 12.6.4. Spain
    • 12.6.5. Italy
    • 12.6.6. Rest of Europe
  • 12.7. Market Attractiveness Analysis
    • 12.7.1. By Product
    • 12.7.2. By Application
    • 12.7.3. By Technology
    • 12.7.4. By End-user
    • 12.7.5. By Country

13. Asia Pacific Molecular Oncology Market Analysis and Forecast

  • 13.1. Introduction
    • 13.1.1. Key Findings
  • 13.2. Market Value Forecast By Product, 2020-2034
    • 13.2.1. Instruments
    • 13.2.2. Reagents
    • 13.2.3. Others
  • 13.3. Market Value Forecast By Application, 2020-2034
    • 13.3.1. Lung Cancer
    • 13.3.2. Breast Cancer
    • 13.3.3. Colorectal Cancer
    • 13.3.4. Ovarian Cancer
    • 13.3.5. Pancreatic Cancer
    • 13.3.6. Others
  • 13.4. Market Value Forecast By Technology, 2020-2034
    • 13.4.1. PCR (rt-PCR, d-PCR)
    • 13.4.2. NGS (Next Generation Sequencing)
    • 13.4.3. Microarray
    • 13.4.4. FISH (Fluorescent in situ-hybridization)
    • 13.4.5. Others
  • 13.5. Market Value Forecast By End-user, 2020-2034
    • 13.5.1. Hospitals and Clinics
    • 13.5.2. Diagnostic Laboratories
    • 13.5.3. Cancer Centers and Specialty Clinics
    • 13.5.4. Others (Government and Public Health Agencies)
  • 13.6. Market Value Forecast By Country, 2020-2034
    • 13.6.1. China
    • 13.6.2. Japan
    • 13.6.3. India
    • 13.6.4. Australia & New Zealand
    • 13.6.5. Rest of Asia Pacific
  • 13.7. Market Attractiveness Analysis
    • 13.7.1. By Product
    • 13.7.2. By Application
    • 13.7.3. By Technology
    • 13.7.4. By End-user
    • 13.7.5. By Country

14. Latin America Molecular Oncology Market Analysis and Forecast

  • 14.1. Introduction
    • 14.1.1. Key Findings
  • 14.2. Market Value Forecast By Product, 2020-2034
    • 14.2.1. Instruments
    • 14.2.2. Reagents
    • 14.2.3. Others
  • 14.3. Market Value Forecast By Application, 2020-2034
    • 14.3.1. Lung Cancer
    • 14.3.2. Breast Cancer
    • 14.3.3. Colorectal Cancer
    • 14.3.4. Ovarian Cancer
    • 14.3.5. Pancreatic Cancer
    • 14.3.6. Others
  • 14.4. Market Value Forecast By Technology, 2020-2034
    • 14.4.1. PCR (rt-PCR, d-PCR)
    • 14.4.2. NGS (Next Generation Sequencing)
    • 14.4.3. Microarray
    • 14.4.4. FISH (Fluorescent in situ-hybridization)
    • 14.4.5. Others
  • 14.5. Market Value Forecast By End-user, 2020-2034
    • 14.5.1. Hospitals and Clinics
    • 14.5.2. Diagnostic Laboratories
    • 14.5.3. Cancer Centers and Specialty Clinics
    • 14.5.4. Others (Government and Public Health Agencies)
  • 14.6. Market Value Forecast By Country, 2020-2034
    • 14.6.1. Brazil
    • 14.6.2. Mexico
    • 14.6.3. Rest of Latin America
  • 14.7. Market Attractiveness Analysis
    • 14.7.1. By Product
    • 14.7.2. By Application
    • 14.7.3. By Technology
    • 14.7.4. By End-user
    • 14.7.5. By Country

15. Middle East & Africa Molecular Oncology Market Analysis and Forecast

  • 15.1. Introduction
    • 15.1.1. Key Findings
  • 15.2. Market Value Forecast By Product, 2020-2034
    • 15.2.1. Instruments
    • 15.2.2. Reagents
    • 15.2.3. Others
  • 15.3. Market Value Forecast By Application, 2020-2034
    • 15.3.1. Lung Cancer
    • 15.3.2. Breast Cancer
    • 15.3.3. Colorectal Cancer
    • 15.3.4. Ovarian Cancer
    • 15.3.5. Pancreatic Cancer
    • 15.3.6. Others
  • 15.4. Market Value Forecast By Technology, 2020-2034
    • 15.4.1. PCR (rt-PCR, d-PCR)
    • 15.4.2. NGS (Next Generation Sequencing)
    • 15.4.3. Microarray
    • 15.4.4. FISH (Fluorescent in situ-hybridization)
    • 15.4.5. Others
  • 15.5. Market Value Forecast By End-user, 2020-2034
    • 15.5.1. Hospitals and Clinics
    • 15.5.2. Diagnostic Laboratories
    • 15.5.3. Cancer Centers and Specialty Clinics
    • 15.5.4. Others (Government and Public Health Agencies)
  • 15.6. Market Value Forecast By Country, 2020-2034
    • 15.6.1. GCC Countries
    • 15.6.2. South Africa
    • 15.6.3. Rest of Middle East & Africa
  • 15.7. Market Attractiveness Analysis
    • 15.7.1. By Product
    • 15.7.2. By Application
    • 15.7.3. By Technology
    • 15.7.4. By End-user
    • 15.7.5. By Country

16. Competition Landscape

  • 16.1. Market Player - Competition Matrix (By Tier and Size of companies)
  • 16.2. Company Profiles
    • 16.2.1. Thermo Fisher Scientific Inc.
      • 16.2.1.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 16.2.1.2. Product Portfolio
      • 16.2.1.3. Financial Overview
      • 16.2.1.4. SWOT Analysis
      • 16.2.1.5. Strategic Overview
    • 16.2.2. Illumina, Inc.
      • 16.2.2.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 16.2.2.2. Product Portfolio
      • 16.2.2.3. Financial Overview
      • 16.2.2.4. SWOT Analysis
      • 16.2.2.5. Strategic Overview
    • 16.2.3. Qiagen N.V.
      • 16.2.3.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 16.2.3.2. Product Portfolio
      • 16.2.3.3. Financial Overview
      • 16.2.3.4. SWOT Analysis
      • 16.2.3.5. Strategic Overview
    • 16.2.4. Agilent Technologies, Inc.
      • 16.2.4.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 16.2.4.2. Product Portfolio
      • 16.2.4.3. Financial Overview
      • 16.2.4.4. SWOT Analysis
      • 16.2.4.5. Strategic Overview
    • 16.2.5. Abbott Laboratories
      • 16.2.5.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 16.2.5.2. Product Portfolio
      • 16.2.5.3. Financial Overview
      • 16.2.5.4. SWOT Analysis
      • 16.2.5.5. Strategic Overview
    • 16.2.6. Bio-Rad Laboratories, Inc.
      • 16.2.6.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 16.2.6.2. Product Portfolio
      • 16.2.6.3. Financial Overview
      • 16.2.6.4. SWOT Analysis
      • 16.2.6.5. Strategic Overview
    • 16.2.7. Roche Diagnostics
      • 16.2.7.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 16.2.7.2. Product Portfolio
      • 16.2.7.3. Financial Overview
      • 16.2.7.4. SWOT Analysis
      • 16.2.7.5. Strategic Overview
    • 16.2.8. Genomic Health, Inc.
      • 16.2.8.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 16.2.8.2. Product Portfolio
      • 16.2.8.3. Financial Overview
      • 16.2.8.4. SWOT Analysis
      • 16.2.8.5. Strategic Overview
    • 16.2.9. Myriad Genetics, Inc.
      • 16.2.9.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 16.2.9.2. Product Portfolio
      • 16.2.9.3. Financial Overview
      • 16.2.9.4. SWOT Analysis
      • 16.2.9.5. Strategic Overview

List of Tables

  • Table 01: Global Molecular Oncology Market Value (US$ Mn) Forecast, by Product, 2020-2034
  • Table 02: Global Molecular Oncology Market Value (US$ Mn) Forecast, by Cancer Type, 2020-2034
  • Table 03: Global Molecular Oncology Market Value (US$ Mn) Forecast, by Technology, 2020-2034
  • Table 04: Global Molecular Oncology Market Value (US$ Mn) Forecast, by End-user, 2020-2034
  • Table 05: Global Molecular Oncology Market Value (US$ Mn) Forecast, by Region, 2020-2034
  • Table 06: North America Molecular Oncology Market Value (US$ Mn) Forecast, by Country, 2020-2034
  • Table 07: North America Molecular Oncology Market Value (US$ Mn) Forecast, by Product, 2020-2034
  • Table 08: North America Molecular Oncology Market Value (US$ Mn) Forecast, by Cancer Type, 2020-2034
  • Table 09: North America Molecular Oncology Market Value (US$ Mn) Forecast, by Technology, 2020-2034
  • Table 10: North America Molecular Oncology Market Value (US$ Mn) Forecast, by End-user, 2020-2034
  • Table 11: Europe Molecular Oncology Market Value (US$ Mn) Forecast, by Country/Sub-region, 2020-2034
  • Table 12: Europe Molecular Oncology Market Value (US$ Mn) Forecast, by Product, 2020-2034
  • Table 13: Europe Molecular Oncology Market Value (US$ Mn) Forecast, by Cancer Type, 2020-2034
  • Table 14: Europe Molecular Oncology Market Value (US$ Mn) Forecast, by Technology, 2020-2034
  • Table 15: Europe Molecular Oncology Market Value (US$ Mn) Forecast, by End-user, 2020-2034
  • Table 16: Asia Pacific Molecular Oncology Market Value (US$ Mn) Forecast, by Country/Sub-region, 2020-2034
  • Table 17: Asia Pacific Molecular Oncology Market Value (US$ Mn) Forecast, by Product, 2020-2034
  • Table 18: Asia Pacific Molecular Oncology Market Value (US$ Mn) Forecast, by Cancer Type, 2020-2034
  • Table 19: Asia Pacific Molecular Oncology Market Value (US$ Mn) Forecast, by Technology, 2020-2034
  • Table 20: Asia Pacific Molecular Oncology Market Value (US$ Mn) Forecast, by End-user, 2020-2034
  • Table 21: Latin America Molecular Oncology Market Value (US$ Mn) Forecast, by Country/Sub-region, 2020-2034
  • Table 22: Latin America Molecular Oncology Market Value (US$ Mn) Forecast, by Product, 2020-2034
  • Table 23: Latin America Molecular Oncology Market Value (US$ Mn) Forecast, by Cancer Type, 2020-2034
  • Table 24: Latin America Molecular Oncology Market Value (US$ Mn) Forecast, by Technology, 2020-2034
  • Table 25: Latin America Molecular Oncology Market Value (US$ Mn) Forecast, by End-user, 2020-2034
  • Table 26: Middle East & Africa Molecular Oncology Market Value (US$ Mn) Forecast, by Country/Sub-region, 2020-2034
  • Table 27: Middle East & Africa Molecular Oncology Market Value (US$ Mn) Forecast, by Product, 2020-2034
  • Table 28: Middle East & Africa Molecular Oncology Market Value (US$ Mn) Forecast, by Cancer Type, 2020-2034
  • Table 29: Middle East & Africa Molecular Oncology Market Value (US$ Mn) Forecast, by Technology, 2020-2034
  • Table 30: Middle East & Africa Molecular Oncology Market Value (US$ Mn) Forecast, by End-user, 2020-2034

List of Figures

  • Figure 01: Global Molecular Oncology Market Value (US$ Mn) Forecast, 2017-2031
  • Figure 02: Global Molecular Oncology Market Value (US$ Mn) Share Analysis, by Product, 2023 and 2034
  • Figure 03: Global Molecular Oncology Market Share Analysis, by Product, 2023
  • Figure 04: Global Molecular Oncology Market Share Analysis, by Product, 2034
  • Figure 05: Global Molecular Oncology Market Attractiveness Analysis, by Type, 2024-2034
  • Figure 06: Global Molecular Oncology Market Value (US$ Mn) Share Analysis, by Cancer Type, 2023 and 2034
  • Figure 07: Global Molecular Oncology Market Share Analysis, by Cancer Type, 2023
  • Figure 08: Global Molecular Oncology Market Share Analysis, by Cancer Type, 2034
  • Figure 09: Global Molecular Oncology Market Attractiveness Analysis, by Cancer Type, 2024-2034
  • Figure 10: Global Molecular Oncology Market Value (US$ Mn) Share Analysis, by Technology, 2023 and 2034
  • Figure 11: Global Molecular Oncology Market Share Analysis, by Technology, 2023
  • Figure 12: Global Molecular Oncology Market Share Analysis, by Technology, 2034
  • Figure 13: Global Molecular Oncology Market Attractiveness Analysis, by Technology, 2024-2034
  • Figure 14: Global Molecular Oncology Market Value (US$ Mn) Share Analysis, by End-user, 2023 and 2034
  • Figure 15: Global Molecular Oncology Market Share Analysis, by End-user, 2023
  • Figure 16: Global Molecular Oncology Market Share Analysis, by End-user, 2034
  • Figure 17: Global Molecular Oncology Market Attractiveness Analysis, by End-user, 2024-2034
  • Figure 18: Global Molecular Oncology Market Value Share Analysis, by Region, 2023 and 2034
  • Figure 19: Global Molecular Oncology Market Share Analysis, by Region, 2023
  • Figure 20: Global Molecular Oncology Market Share Analysis, by Region, 2034
  • Figure 21: Global Molecular Oncology Market Attractiveness Analysis, by Region, 2023-2034
  • Figure 22: North America Molecular Oncology Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2020-2034
  • Figure 23: North America Molecular Oncology Market Value Share Analysis, by Country, 2023 and 2034
  • Figure 24: North America Molecular Oncology Market Attractiveness Analysis, by Country, 2024-2034
  • Figure 25: North America Molecular Oncology Market Value (US$ Mn) Share Analysis, by Product, 2023 and 2034
  • Figure 26: North America Molecular Oncology Market Attractiveness Analysis, by Product, 2024-2034
  • Figure 27: North America Molecular Oncology Market Value (US$ Mn) Share Analysis, by Cancer Type, 2023 and 2034
  • Figure 28: North America Molecular Oncology Market Attractiveness Analysis, by Cancer Type, 2024-2034
  • Figure 29: North America Molecular Oncology Market Value (US$ Mn) Share Analysis, by Technology, 2023 and 2034
  • Figure 30: North America Molecular Oncology Market Attractiveness Analysis, by Technology, 2024-2034
  • Figure 31: North America Molecular Oncology Market Value (US$ Mn) Share Analysis, by End-user, 2023 and 2034
  • Figure 32: North America Molecular Oncology Market Attractiveness Analysis, by End-user, 2024-2034
  • Figure 33: Europe Molecular Oncology Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2020-2034
  • Figure 34: Europe Molecular Oncology Market Value Share Analysis, by Country/Sub-region, 2023 and 2034
  • Figure 35: Europe Molecular Oncology Market Attractiveness Analysis, by Country/Sub-region, 2024-2034
  • Figure 36: North America Molecular Oncology Market Value (US$ Mn) Share Analysis, by Product, 2023 and 2034
  • Figure 37: North America Molecular Oncology Market Attractiveness Analysis, by Product, 2024-2034
  • Figure 38: Europe Molecular Oncology Market Value (US$ Mn) Share Analysis, by Cancer Type, 2023 and 2034
  • Figure 39: Europe Molecular Oncology Market Attractiveness Analysis, by Cancer Type, 2024-2034
  • Figure 40: Europe Molecular Oncology Market Value (US$ Mn) Share Analysis, by Technology, 2023 and 2034
  • Figure 41: Europe Molecular Oncology Market Attractiveness Analysis, by Technology, 2024-2034
  • Figure 42: Europe Molecular Oncology Market Value (US$ Mn) Share Analysis, by End-user, 2023 and 2034
  • Figure 43: Europe Molecular Oncology Market Attractiveness Analysis, by End-user, 2024-2034
  • Figure 44: Asia Pacific Molecular Oncology Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2020-2034
  • Figure 45: Asia Pacific Molecular Oncology Market Value Share Analysis, by Country/Sub-region, 2023 and 2034
  • Figure 46: Asia Pacific Molecular Oncology Market Attractiveness Analysis, by Country/Sub-region, 2024-2034
  • Figure 47: Asia Pacific Molecular Oncology Market Value (US$ Mn) Share Analysis, by Product, 2023 and 2034
  • Figure 48: Asia Pacific Molecular Oncology Market Attractiveness Analysis, by Product, 2024-2034
  • Figure 49: Asia Pacific Molecular Oncology Market Value (US$ Mn) Share Analysis, by Cancer Type, 2023 and 2034
  • Figure 50: Asia Pacific Molecular Oncology Market Attractiveness Analysis, by Cancer Type, 2024-2034
  • Figure 51: Asia Pacific Molecular Oncology Market Value (US$ Mn) Share Analysis, by Technology, 2023 and 2034
  • Figure 52: Asia Pacific Molecular Oncology Market Attractiveness Analysis, by Technology, 2024-2034
  • Figure 53: Asia Pacific Molecular Oncology Market Value (US$ Mn) Share Analysis, by End-user, 2023 and 2034
  • Figure 54: Asia Pacific Molecular Oncology Market Attractiveness Analysis, by End-user, 2024-2034
  • Figure 55: Latin America Molecular Oncology Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2020-2034
  • Figure 56: Latin America Molecular Oncology Market Value Share Analysis, by Country/Sub-region, 2023 and 2034
  • Figure 57: Latin America Molecular Oncology Market Attractiveness Analysis, by Country/Sub-region, 2024-2034
  • Figure 58: Latin America Molecular Oncology Market Value (US$ Mn) Share Analysis, by Product, 2023 and 2034
  • Figure 59: Latin America Molecular Oncology Market Attractiveness Analysis, by Product, 2024-2034
  • Figure 60: Latin America Molecular Oncology Market Value (US$ Mn) Share Analysis, by Cancer Type, 2023 and 2034
  • Figure 61: Latin America Molecular Oncology Market Attractiveness Analysis, by Cancer Type, 2024-2034
  • Figure 62: Latin America Molecular Oncology Market Value (US$ Mn) Share Analysis, by Technology, 2023 and 2034
  • Figure 63: Latin America Molecular Oncology Market Attractiveness Analysis, by Technology, 2024-2034
  • Figure 64: Latin America Molecular Oncology Market Value (US$ Mn) Share Analysis, by End-user, 2023 and 2034
  • Figure 65: Latin America Molecular Oncology Market Attractiveness Analysis, by End-user, 2024-2034
  • Figure 66: Middle East & Africa Molecular Oncology Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2020-2034
  • Figure 67: Middle East & Africa Molecular Oncology Market Value Share Analysis, by Country/Sub-region, 2023 and 2034
  • Figure 68: Middle East & Africa Molecular Oncology Market Attractiveness Analysis, by Country/Sub-region, 2024-2034
  • Figure 69: Middle East & Africa Molecular Oncology Market Value (US$ Mn) Share Analysis, by Product, 2023 and 2034
  • Figure 70: Middle East & Africa Molecular Oncology Market Attractiveness Analysis, by Product, 2024-2034
  • Figure 71: Middle East & Africa Molecular Oncology Market Value (US$ Mn) Share Analysis, by Cancer Type, 2023 and 2034
  • Figure 72: Middle East & Africa Molecular Oncology Market Attractiveness Analysis, by Cancer Type, 2024-2034
  • Figure 73: Middle East & Africa Molecular Oncology Market Value (US$ Mn) Share Analysis, by Technology, 2023 and 2034
  • Figure 74: Middle East & Africa Molecular Oncology Market Attractiveness Analysis, by Technology, 2024-2034
  • Figure 75: Middle East & Africa Molecular Oncology Market Value (US$ Mn) Share Analysis, by End-user, 2023 and 2034
  • Figure 76: Middle East & Africa Molecular Oncology Market Attractiveness Analysis, by End-user, 2024-2034